{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:47:28Z","timestamp":1758638848555},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1992,7]]},"DOI":"10.1212\/wnl.42.7.1391","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:04:38Z","timestamp":1336914278000},"page":"1391-1391","update-policy":"http:\/\/dx.doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Botulinum toxin treatment of supranuclear ocular motility disorders"],"prefix":"10.1212","volume":"42","author":[{"given":"Nancy J.","family":"Newman","sequence":"first","affiliation":[{"name":"Department of Opthalmology (Drs. Newman and Lambert) and Neurology (Dr, Newman), Emory University School of Medicine, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.42.7.1391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:40:56Z","timestamp":1711550456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.42.7.1391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1992,7]]}},"alternative-id":["10.1212\/WNL.42.7.1391"],"URL":"https:\/\/doi.org\/10.1212\/wnl.42.7.1391","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,7]]}}}